DAWNZERA
NDC 71860-103, donidalorsen, injection, solution, from Ionis Pharmaceuticals Inc..
- Product NDC
- 71860-103
- Status
- Listed
- Labeler
- Ionis Pharmaceuticals Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219407
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71860-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DONIDALORSEN SODIUM80 mg/.8mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71860-103-01 | 71860010301 | 1 SYRINGE, GLASS in 1 CARTON (71860-103-01) / .8 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3ff501e0-f75f-07da-e063-6294a90a0cb7
Use it
Look up 71860-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71860-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71860-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.